Published in Nucleic Acids Res on February 15, 2003
Recombinant influenza A viruses with enhanced levels of PB1 and PA viral protein expression. J Virol (2012) 0.87
Activation of the interferon induction cascade by influenza a viruses requires viral RNA synthesis and nuclear export. J Virol (2014) 0.83
A novel small-molecule binds to the influenza A virus RNA promoter and inhibits viral replication. Chem Commun (Camb) (2013) 0.82
Rapid sequencing of influenza A virus vRNA, cRNA and mRNA non-coding regions. J Virol Methods (2013) 0.80
U4 at the 3' UTR of PB1 segment of H5N1 influenza virus promotes RNA polymerase activity and contributes to viral pathogenicity. PLoS One (2014) 0.76
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry (1994) 13.94
Mechanism and control of transcription initiation in prokaryotes. Annu Rev Biochem (1985) 11.99
The 3' and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity. Gene (1980) 5.08
5' and 3' terminal nucleotide sequences of the RNA genome segments of influenza virus. Nucleic Acids Res (1979) 4.90
Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle. Proc Natl Acad Sci U S A (1987) 4.31
The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J Gen Virol (2002) 3.77
Synthesis and purification of large amounts of RNA oligonucleotides. Biotechniques (1991) 3.57
The influenza virus panhandle is involved in the initiation of transcription. J Virol (1994) 3.56
Sequence-specific binding of the influenza virus RNA polymerase to sequences located at the 5' ends of the viral RNAs. J Virol (1994) 3.41
Recombinant influenza virus polymerase: requirement of both 5' and 3' viral ends for endonuclease activity. J Virol (1994) 3.39
Promoter elements in the influenza vRNA terminal structure. RNA (1996) 2.97
Structure of influenza virus RNP. I. Influenza virus nucleoprotein melts secondary structure in panhandle RNA and exposes the bases to the solvent. EMBO J (1994) 2.93
Structure of the P1 helix from group I self-splicing introns. J Mol Biol (1995) 2.84
A novel loop-loop recognition motif in the yeast ribosomal protein L30 autoregulatory RNA complex. Nat Struct Biol (1999) 2.80
Mutational analysis of influenza virus promoter elements in vivo. J Gen Virol (1995) 2.59
Characterization of the RNA-fork model of virion RNA in the initiation of transcription in influenza A virus. J Virol (1995) 2.52
Assignment of the 31P and 1H resonances in oligonucleotides by two-dimensional NMR spectroscopy. FEBS Lett (1986) 2.28
Differential activation of the influenza virus polymerase via template RNA binding. J Virol (1995) 2.18
1.9 A resolution refined structure of TBP recognizing the minor groove of TATAAAAG. Nat Struct Biol (1994) 2.17
Photochemical cross-linking of influenza A polymerase to its virion RNA promoter defines a polymerase binding site at residues 9 to 12 of the promoter. J Gen Virol (1993) 2.17
Nonconserved nucleotides at the 3' and 5' ends of an influenza A virus RNA play an important role in viral RNA replication. Virology (1996) 2.03
FUNCTIONS OF THE 3'-UNTRANSLATED REGIONS OF POSITIVE STRAND RNA VIRAL GENOMES. Annu Rev Phytopathol (1999) 1.99
5'-terminus of influenza virus RNA. Nat New Biol (1971) 1.93
Interaction of influenza virus polymerase with viral RNA in the 'corkscrew' conformation. J Gen Virol (1999) 1.88
Polyadenylation of influenza virus mRNA transcribed in vitro from model virion RNA templates: requirement for 5' conserved sequences. J Virol (1998) 1.68
Probing molecular motion by NMR. Curr Opin Struct Biol (1997) 1.57
Structural features of an influenza virus promoter and their implications for viral RNA synthesis. Proc Natl Acad Sci U S A (2001) 1.53
Characterization of influenza virus PB1 protein binding to viral RNA: two separate regions of the protein contribute to the interaction domain. J Virol (1999) 1.52
Structure and function of the influenza virus genome. Biochem J (1983) 1.47
Mutational analysis of the RNA-fork model of the influenza A virus vRNA promoter in vivo. J Gen Virol (1997) 1.37
The packaging signal of influenza viral RNA molecules. RNA (2001) 1.35
In vitro transcription and polymerase binding studies of the termini of influenza A virus cRNA: evidence for a cRNA panhandle. J Gen Virol (1995) 1.35
Polypeptides specified by the influenza virus genome. 3. Control of synthesis in infected cells. Virology (1979) 1.31
Hairpin loop structure in the 3' arm of the influenza A virus virion RNA promoter is required for endonuclease activity. J Virol (2001) 1.23
Rotavirus RNA replication requires a single-stranded 3' end for efficient minus-strand synthesis. J Virol (1998) 1.22
DNA bends in TATA-binding protein-TATA complexes in solution are DNA sequence-dependent. J Biol Chem (2001) 1.20
Recognition of pre-formed and flexible elements of an RNA stem-loop by nucleolin. J Mol Biol (2001) 1.10
Transient bicistronic vRNA segments for indirect selection of recombinant influenza viruses. Virology (1999) 1.03
Structural features of the binding site for ribosomal protein S8 in Escherichia coli 16S rRNA defined using NMR spectroscopy. Proc Natl Acad Sci U S A (1997) 0.96
Solution structure of the donor site of a trans-splicing RNA. Structure (1996) 0.96
Comparison of TATA-binding protein recognition of a variant and consensus DNA promoters. J Biol Chem (2001) 0.89
3D HCCH-COSY-TOCSY experiment for the assignment of ribose and amino acid side chains in 13C labeled RNA and protein. J Biomol NMR (1998) 0.88
The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature (2009) 8.99
Structure of H/ACA RNP protein Nhp2p reveals cis/trans isomerization of a conserved proline at the RNA and Nop10 binding interface. J Mol Biol (2011) 1.53
Binding surface mapping of intra- and interdomain interactions among hHR23B, ubiquitin, and polyubiquitin binding site 2 of S5a. J Biol Chem (2003) 1.52
Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway. Proc Natl Acad Sci U S A (2007) 1.50
Structure of PP4397 reveals the molecular basis for different c-di-GMP binding modes by Pilz domain proteins. J Mol Biol (2010) 1.34
Structure of an atypical orphan response regulator protein supports a new phosphorylation-independent regulatory mechanism. J Biol Chem (2007) 1.30
Mechanism of anchoring of OmpA protein to the cell wall peptidoglycan of the gram-negative bacterial outer membrane. FASEB J (2011) 1.25
NMR relaxation study of the complex formed between CBP and the activation domain of the nuclear hormone receptor coactivator ACTR. Biochemistry (2008) 1.12
Design of a binding scaffold based on variable lymphocyte receptors of jawless vertebrates by module engineering. Proc Natl Acad Sci U S A (2012) 1.11
Rapid preparation of RNA samples for NMR spectroscopy and X-ray crystallography. Nucleic Acids Res (2004) 1.09
The protein shuffle. Sequential interactions among components of the human nucleotide excision repair pathway. FEBS J (2006) 1.05
Structure of human PRL-3, the phosphatase associated with cancer metastasis. FEBS Lett (2004) 1.02
In vivo tracking of human mesenchymal stem cells in experimental stroke. Cell Transplant (2008) 0.99
Tetraspan TM4SF5-dependent direct activation of FAK and metastatic potential of hepatocarcinoma cells. J Cell Sci (2012) 0.96
NMR spectroscopic elucidation of the B-Z transition of a DNA double helix induced by the Z alpha domain of human ADAR1. J Am Chem Soc (2009) 0.95
Structural snapshots of heparin depolymerization by heparin lyase I. J Biol Chem (2009) 0.92
Residual structure within the disordered C-terminal segment of p21(Waf1/Cip1/Sdi1) and its implications for molecular recognition. Protein Sci (2009) 0.92
Structural basis of E2-25K/UBB+1 interaction leading to proteasome inhibition and neurotoxicity. J Biol Chem (2010) 0.92
Expression, purification and biochemical characterization of the N-terminal regions of human TIG3 and HRASLS3 proteins. Protein Expr Purif (2010) 0.92
The human Cdc34 carboxyl terminus contains a non-covalent ubiquitin binding activity that contributes to SCF-dependent ubiquitination. J Biol Chem (2010) 0.91
Development of cyclic peptomer inhibitors targeting the polo-box domain of polo-like kinase 1. Bioorg Med Chem (2013) 0.91
Structural and dynamic basis of a supercoiling-responsive DNA element. Nucleic Acids Res (2006) 0.90
Plk1-targeted small molecule inhibitors: molecular basis for their potency and specificity. Mol Cells (2011) 0.90
Subcellular in vivo 1H MR spectroscopy of Xenopus laevis oocytes. Biophys J (2005) 0.89
NMR application probes a novel and ubiquitous family of enzymes that alter monosaccharide configuration. J Biol Chem (2004) 0.89
Intrinsically unstructured N-terminal domain of bZIP transcription factor HY5. Proteins (2006) 0.89
Cnu, a novel oriC-binding protein of Escherichia coli. J Bacteriol (2005) 0.89
Structure and function of the regulatory HRDC domain from human Bloom syndrome protein. Nucleic Acids Res (2010) 0.88
Solution structure of the DNA-binding domain of RPA from Saccharomyces cerevisiae and its interaction with single-stranded DNA and SV40 T antigen. Nucleic Acids Res (2005) 0.87
Structure of the Cdt1 C-terminal domain: conservation of the winged helix fold in replication licensing factors. Protein Sci (2009) 0.87
Direct characterization of E2-dependent target specificity and processivity using an artificial p27-linker-E2 ubiquitination system. BMB Rep (2008) 0.86
Magnetic resonance microscopic imaging based on high-order intermolecular multiple-quantum coherences. Magn Reson Imaging (2007) 0.86
Structural characterization reveals that a PilZ domain protein undergoes substantial conformational change upon binding to cyclic dimeric guanosine monophosphate. Protein Sci (2010) 0.86
Solution structure of the influenza A virus cRNA promoter: implications for differential recognition of viral promoter structures by RNA-dependent RNA polymerase. Nucleic Acids Res (2003) 0.85
pH-dependent structural change of the extracellular sensor domain of the DraK histidine kinase from Streptomyces coelicolor. Biochem Biophys Res Commun (2013) 0.85
NMR study on the interaction between RPA and DNA decamer containing cis-syn cyclobutane pyrimidine dimer in the presence of XPA: implication for damage verification and strand-specific dual incision in nucleotide excision repair. Nucleic Acids Res (2003) 0.85
Prediction of RNA 1H and 13C chemical shifts: a structure based approach. J Phys Chem B (2013) 0.85
60th residues of ubiquitin and Nedd8 are located out of E2-binding surfaces, but are important for K48 ubiquitin-linkage. FEBS Lett (2009) 0.85
Biophysical characterization of the interaction domains and mapping of the contact residues in the XPF-ERCC1 complex. J Biol Chem (2005) 0.85
Noninvasive assessment of myocardial inflammation by cardiovascular magnetic resonance in a rat model of experimental autoimmune myocarditis. Circulation (2012) 0.85
NMR analysis of enzyme-catalyzed and free-equilibrium mutarotation kinetics of monosaccharides. J Am Chem Soc (2004) 0.84
The N-terminal domain of human holocarboxylase synthetase facilitates biotinylation via direct interaction with the substrate protein. FEBS Lett (2010) 0.84
Structural and dynamics study of DNA dodecamer duplexes that contain un-, hemi-, or fully methylated GATC sites. J Am Chem Soc (2008) 0.84
Structure of the N-terminal extension of human aspartyl-tRNA synthetase: implications for its biological function. Int J Biochem Cell Biol (2003) 0.84
Structural basis for the conformational integrity of the Arabidopsis thaliana HY5 leucine zipper homodimer. J Biol Chem (2007) 0.84
Structure of the nucleoid-associated protein Cnu reveals common binding sites for H-NS in Cnu and Hha. Biochemistry (2008) 0.83
Proteomic and bioinformatic analysis of membrane proteome in type 2 diabetic mouse liver. Proteomics (2013) 0.83
Exploring the binding nature of pyrrolidine pocket-dependent interactions in the polo-box domain of polo-like kinase 1. PLoS One (2013) 0.83
NMR study on the B-Z junction formation of DNA duplexes induced by Z-DNA binding domain of human ADAR1. J Am Chem Soc (2012) 0.83
Structure of the DNA-binding domain of NgTRF1 reveals unique features of plant telomere-binding proteins. Nucleic Acids Res (2008) 0.83
MR microscopy of micron scale structures. Magn Reson Imaging (2009) 0.83
Structure and dynamics of hemimethylated GATC sites: implications for DNA-SeqA recognition. J Biol Chem (2003) 0.83
NMR structure of the DNA decamer duplex containing double T*G mismatches of cis-syn cyclobutane pyrimidine dimer: implications for DNA damage recognition by the XPC-hHR23B complex. Nucleic Acids Res (2004) 0.82
Discovery of novel histidine-derived lipo-amino acids: applied in the synthesis of ultra-short antimicrobial peptidomimetics having potent antimicrobial activity, salt resistance and protease stability. Eur J Med Chem (2013) 0.82
Structural determination of the N-glycans of a lepidopteran arylphorin reveals the presence of a monoglucosylated oligosaccharide in the storage protein. Glycobiology (2002) 0.82
Identification of structurally diverse alkaloids in Corydalis species by liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom (2012) 0.82
Non hemolytic short peptidomimetics as a new class of potent and broad-spectrum antimicrobial agents. Bioorg Med Chem Lett (2013) 0.82
A novel small-molecule binds to the influenza A virus RNA promoter and inhibits viral replication. Chem Commun (Camb) (2013) 0.82
Thermodynamics and kinetics for base pair opening in the DNA decamer duplexes containing cyclobutane pyrimidine dimer. FEBS Lett (2009) 0.82
Structural insights into the monosaccharide specificity of Escherichia coli rhamnose mutarotase. J Mol Biol (2005) 0.81
In vivo magnetic resonance microscopy of differentiation in Xenopus laevis embryos from the first cleavage onwards. Differentiation (2007) 0.81
Srs2 possesses a non-canonical PIP box in front of its SBM for precise recognition of SUMOylated PCNA. J Mol Cell Biol (2012) 0.81
A new class of peptidomimetics targeting the polo-box domain of Polo-like kinase 1. J Med Chem (2014) 0.81
An activatable prodrug for the treatment of metastatic tumors. J Am Chem Soc (2014) 0.81
Biotinoyl domain of human acetyl-CoA carboxylase: Structural insights into the carboxyl transfer mechanism. Proteins (2008) 0.80
Solution structure of the Zbeta domain of human DNA-dependent activator of IFN-regulatory factors and its binding modes to B- and Z-DNAs. Proc Natl Acad Sci U S A (2011) 0.80
Crystal structures of the LsrR proteins complexed with phospho-AI-2 and two signal-interrupting analogues reveal distinct mechanisms for ligand recognition. J Am Chem Soc (2013) 0.80
Replication protein A 32 interacts through a similar binding interface with TIPIN, XPA, and UNG2. Int J Biochem Cell Biol (2010) 0.80
Development and biological evaluation of potent and selective c-KIT(D816V) inhibitors. J Med Chem (2014) 0.79
Sequence discrimination of the Zα domain of human ADAR1 during B-Z transition of DNA duplexes. FEBS Lett (2010) 0.79
The presence of monoglucosylated N196-glycan is important for the structural stability of storage protein, arylphorin. Biochem J (2009) 0.79
Solution structure and backbone dynamics of the XPC-binding domain of the human DNA repair protein hHR23B. FEBS J (2005) 0.78
Intratympanic manganese administration revealed sound intensity and frequency dependent functional activity in rat auditory pathway. Magn Reson Imaging (2013) 0.78
Insights into the regulation of human Rev1 for translesion synthesis polymerases revealed by the structural studies on its polymerase-interacting domain. J Mol Cell Biol (2012) 0.78
Expression and characterization of the integral membrane domain of bacterial histidine kinase SCO3062 for structural studies. Biochem Biophys Res Commun (2008) 0.78
Aminoglycoside antibiotics bind to the influenza A virus RNA promoter. Mol Biosyst (2012) 0.78